Evidence map›Paper›PMID 37392214›Full record

ArticleAnalytical and bioanalytical chemistry2023

Efficient interfacial self-assembled MXene/Ag NPs film nanocarriers for SERS-traceable drug delivery.

Yi Chen, Cailing Jiang, Feixiang Huang, Zizhen Yu, Li Jiang

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yi ChenCollege of Optical and Electronic Technology, China Jiliang University, Hangzhou, 310018, People's Republic of China.
Cailing JiangCollege of Optical and Electronic Technology, China Jiliang University, Hangzhou, 310018, People's Republic of China.
Feixiang HuangDepartment of TCM Gynecology, Hangzhou Women's Hospital, Hangzhou, 310008, People's Republic of China. fxhuang2009@163.com.
Zizhen YuCollege of Optical and Electronic Technology, China Jiliang University, Hangzhou, 310018, People's Republic of China.
Li JiangCollege of Optical and Electronic Technology, China Jiliang University, Hangzhou, 310018, People's Republic of China. lijiang@cjlu.edu.cn.ORCID http://orcid.org/0000-0003-2652-0699
China Jiliang University · CNHangzhou Women’s Hospital · CN

Funding

Fundamental Research Funds for the Provincial Universities of Zhejiang 2021YW03National Natural Science Foundation of China 51972292National Natural Science Foundation of China 52271139Natural Science Foundation of Zhejiang Province LZ22F050004
6 · The paper itself

Abstract

Combining the unique advantages of two-dimensional transition metal carbon/nitrogen compounds (MXene) and the excellent surface-enhanced Raman scattering (SERS) performance of noble metal materials, MXene/Ag NPs films were proposed as nanocarriers for SERS-traceable drug delivery. The films were prepared by two-step self-assembly on positively charged silicon wafers using virtue of the high evaporation of ethyl acetate, the Marangoni effect, and an oil/water/oil three-phase system. With 4-mercaptobenzoic acid (4-MBA) as the probe molecule, the SERS detection limit was 10

Indexed as

Antineoplastic AgentsDrug Delivery SystemsDoxorubicinNitritesSpectrum Analysis, RamanSulfhydryl CompoundsTransition Elements4-mercaptobutyramidineAntineoplastic AgentsDoxorubicinMXeneNitritesSulfhydryl CompoundsTransition ElementsGSHMXeneNanocarrierSERS

Identifiers

PMID37392214
OpenAlexW4382795804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.